Privet

Privet (Ligustrum lucidum W.T. Aiton): A Comprehensive Reference

1. Identity and Botanical Description

1.1 Nomenclature and Taxonomy

Ligustrum lucidum W.T. Aiton, also known as glossy privet, is a popular species of flowering plant that belongs to the olive family Oleaceae. It is also variously known as broad-leaf privet, Chinese privet, tree privet, and wax-leaf privet. The Latin specific epithet lucidum means "bright" or "shiny," referring to the leaves. In Traditional Chinese Medicine (TCM), the ripe fruit is known as Nu Zhen Zi (女貞子) or Ligustri Lucidi Fructus, and its prepared medicinal form is often referred to as Fructus Ligustri Lucidi (abbreviated FLL).

The name "Chinese privet" is also used for Ligustrum sinense, a closely related but distinct species. Other species in the genus Ligustrum, including Ligustrum japonicum, are occasionally used in related medicinal preparations, though L. lucidum is the primary species referenced in the official Chinese Pharmacopoeia.

1.2 Botanical Description and Natural Range

Ligustrum lucidum is a species of privet (genus Ligustrum), a flowering plant in the olive family, native to the southern half of China and naturalized in many places. It is an evergreen tree growing to 33 ft tall and broad, with opposite, glossy dark green leaves that are 2.4–6.7 in long and 1.2–3.1 in broad. The flowers are similar to other privets, white or near white, borne in panicles, and unpleasantly pungent.

The fruit is an oblong blue-black drupe about 0.25 in (0.6 cm) long that persists on the plant much of the year. It has been cultivated and distributed in most areas of China and many parts of the world since ancient times, and has rich plant resources.

It has become an invasive species in some areas where it has been introduced, such as urban areas in the southeastern United States. It is classed as a noxious weed in New South Wales, Australia, and is similarly listed in New Zealand's National Pest Plant Accord.

1.3 The Medicinal Part and Its Preparation

The ripe fruits of Ligustrum lucidum Ait. are known as Ligustri Lucidi Fructus (LLF). The fruits are plucked from the branches and leaves in the winter when they are ripe, lightly steamed or scalded in boiling water, and then dried; or they may be dried immediately. LLF is 6–8.5 mm long, 3.5–5.5 mm in diameter, and ovate, ellipsoid, or reniform in shape, with the surface crinkled, uneven, and black-purple or grey-black.

1.4 Common Forms and Preparations

Privet fruit is commercially available in the following forms:

• Dried raw fruit (decoction-grade): FLL is currently administered as a Chinese medicine powder or as traditional decoctions.
• Standardized dry extract capsules and tablets: Concentrated powders standardized to oleanolic acid content.
• Dropping pills (solid dispersion): A solid dispersion technique has been used to successfully produce FLL dropping pills, improving the water insolubility of FLL and increasing the dissolution release percentage of the drug.
• Alcohol tinctures/liquid extracts: A common modern commercial preparation in which the dried fruit is macerated in alcohol and water.
• Multi-herb classical formulas: In the 2020 Edition of the Chinese Pharmacopoeia, there are more than 100 prescriptions containing L. lucidum W.T. Aiton. Among them, some classical preparations including Er Zhi Wan and Zhenqi fuzheng formula are used in the treatment of various cancers with good therapeutic effects.
• Herbal tea: It is also consumed as herbal tea in Korea and India.

2. Traditional and Historical Use

2.1 Chinese Medical Tradition (TCM)

Ligustrum lucidum Aiton and its berries have been used in Chinese traditional medicine for around two thousand years. LLF was first recorded in the Shennong Materia Medica (Shennong Bencao Jing) and listed as a top-grade herb. In that classification system, top-grade herbs were those considered nourishing, non-toxic, and suitable for extended use.

The Compendium of Materia Medica (Bencao Gangmu) records that "the leaves of the LLF resemble holly trees." The fruit is described by Li Shizhen as able to strengthen the Yin, strengthen the waist and knees, transform white hair, and improve eyesight, referring to the plant now known as the wax tree.

In Traditional Chinese Medicine, Ligustrum—referred to as "Nu Zhen Zi"—is regarded as a vital tonic herb. It is believed to nourish the liver and kidneys, support healthy vision, and promote overall vitality and longevity.

Traditionally, the leaves and fruits are obtained, dried, and used in clinical practice for several purposes, such as preventing aging and hair graying, improving vision, alleviating the soreness and weakness of the waist and knees, and strengthening human energy in its native and introduced areas.

As recorded in the Chinese Pharmacopoeia, it is sweet, bitter, and cool in nature. It has the efficacies of nourishing the liver and the kidney, brightening eyes and blackening the hair, with a traditional dosage of 6–12 g. Clinically it is used to treat yin-deficiency of the liver and kidney, dizziness, tinnitus, weak waist and knees, premature graying of the beard and hair, dim eyes, internal heat, diabetes, and hectic fever.

The berries of the glossy privet tree Ligustrum lucidum have a long history of use in traditional Chinese herbal medicine as an herb that helps "tonify the yin." This expression may be said loosely to indicate a strengthening effect on some of the body's functions. As part of herbal combinations (traditional Chinese herbal medicine seldom uses single-herb preparations), ligustrum is used for such purposes as turning gray hair black, alleviating ringing in the ear, and improving vision.

Ligustrum lucidum is not only a unique herbal remedy for tonifying the liver and kidney in TCM, but also a significant medicine-food homology (MFH) material released by the China Food and Drug Administration (CFDA). In other words, L. lucidum has been applied as both food and medicine in numerous conventional medical systems throughout history.

2.2 The Er Zhi Wan Classical Formula

Er Zhi Wan is a two-ingredient formulation that is frequently mentioned in modern Chinese medical literature. The pair of herbs—ligustrum and eclipta—are sometimes used as is, but more commonly they are incorporated into somewhat larger prescriptions. Er Zhi Wan was first recorded in the Fu Shou Jing Fang in the Ming Dynasty. It consists of an equal weight mixture of two herbs, Fructus Ligustri Lucidi (FLL, Nü-Zhen-Zi) and Ecliptae Herba (EH, Mo-Han-Lian). According to Chinese medicinal theory, EZW is commonly used clinically in China for the treatment of liver-kidney yin deficiency syndrome (LKYDS), which is a pathological and diagnostic pattern caused by an imbalance of yin and yang.

The formula name, which might be better translated as "Two Solstices Pill," refers to when the herbs are routinely collected: each of the herbs is picked near the time of the solstice. Specifically, ligustrum is picked at the winter solstice when its fruits are ripe, while eclipta is picked at the summer solstice while in flower. The formula was recorded by Wang Ang in his 1682 A.D. publication Yifang Jijie (Collection of Medical Formulas).

2.3 Other Traditional Uses

Chinese privet has been used in traditional Chinese medicine for over 1,000 years. The fruit is described traditionally as antibacterial, antiseptic, antitumour, cardiotonic, diuretic, and tonic. It is taken internally in the treatment of complaints associated with weak kidney and liver energy, such as menopausal problems (especially premature menopause), blurred vision, cataracts, tinnitus, rheumatic pains, palpitations, backache, and insomnia.

The leaves of Ligustrum lucidum have also been used as antipyretics, analgesics, and anti-inflammatory agents within the same tradition. Both Ligustrum lucidum (Chinese privet) and Ligustrum vulgare (European privet) have a long history in traditional medicine, particularly in Chinese and European herbalism, where they were used for their supposed ability to boost immunity, treat respiratory issues, and improve liver health.

3. Key Constituents and Phytochemistry

Ligustrum lucidum W.T. Aiton is rich in nutritional components and a variety of bioactive ingredients. A total of 206 compounds have been isolated and identified, mainly including flavonoids, phenylpropanoids, iridoid glycosides, and triterpenoids. These compounds exert anti-osteoporosis, anti-tumor, liver-protective, antioxidant, anti-inflammatory, and immunomodulatory effects.

3.1 Triterpenoids

Forty-two triterpenoids have been separated and characterized based on spectroscopic and chemical analysis from the fruits of L. lucidum.

Oleanolic acid and ursolic acid are a pair of isomers that are among the ubiquitous triterpenoids in various medicinal plants. These two compounds are the main effective constituents in this well-respected medicinal herb, and were used as the chemical markers for quality evaluation of L. lucidum preparations in the 2015 Chinese Pharmacopoeia.

Oleanolic acid belongs to the oleanane type pentacyclic triterpenes. Many studies have shown that oleanolic acid has the pharmacological effects of liver protection, antioxidation, hypolipidemia, antitumor, anti-inflammatory, and antiviral activity. However, due to its poor water solubility and low bioavailability of oral administration, its development in the pharmaceutical field has been limited.

Oleanolic acid and ursolic acid are the main bioactive compounds in the fruit of Ligustrum lucidum Ait., which possess anti-inflammatory, antioxidative, antiprotozoal, antimutagenic, and anticancer properties.

3.2 Secoiridoid Glycosides

The secoiridoid glycosides are another major and pharmacologically significant class. Key members identified include:

• Nuzhenide and specnuezhenide (also spelled specnuzheniside): among the most abundant and characteristic secoiridoids of L. lucidum.
• Oleuropein: a secoiridoid shared with olives (Olea europaea) and well-studied for antioxidant and antiviral properties.
• Salidroside (also found in Rhodiola rosea): a phenylethanoid glycoside with documented pharmacological activity.

The chemical structures of the main active ingredients isolated from Fructus Ligustri Lucidi include: oleanolic acid, ursolic acid, nuzhenide, specneuzhenide, neuzhengalaside, nuezhenoside G13, oleuropein, oleuropeinic acid, oleoside dimethyl ester, oleoside-7-ethyl-11-methyl ester, salidroside, hydroxytyrosol, tyrosol, and tyrosyl acetate.

Oleanolic acid, ursolic acid, salidroside, and nuzhenide have been reported to exhibit anti-osteoporosis effects.

Ethanol extract of Ligustrum lucidum fruits and its secoiridoid glucosides, namely oleoside dimethylester, oleuropein, neonuezhenide, lucidumoside B, and lucidumoside C, were shown to inhibit free radical-induced hemolysis in red blood cells. Oleuropein also exhibited antiviral activities against respiratory syncytial virus (RSV) and parainfluenza type 3 virus.

3.3 Flavonoids

Research has focused on a range of flavonoids and phenolic acids in L. lucidum, including maslinic acid, oleuropein, salidroside, verbascoside, apigenin, luteolin, tyrosol, quercetin, apigenin-7-O-glucoside, eriodictyol, kaempferol, oleanic acid, ursolic acid, rutin, echinacoside, and nuezhenoside G13.

3.4 Polysaccharides

Ligustrum lucidum polysaccharide is present in the fruit, with the polysaccharide content of processed products at approximately 8.7041–9.516 mg/g. Ligustrum lucidum polysaccharide is mainly composed of fucose, glucose, arabinose, and rhamnose with a molar ratio of 1.80:4.58:2.55:1.91.

3.5 Nutritional Components

The content of protein in L. lucidum is 80.3 g/kg, and the content of free amino acid is 2.9 mg/kg. Researchers have identified about 21 amino acids (including 8 essential amino acids) in L. lucidum.

3.6 Key Bioavailability Note

The active ingredient with the highest FLL content is oleanolic acid, a triterpenoid compound that is practically insoluble in water (1.748 μg/L). The traditional decoction is prepared by decocting with water, which is not conducive to the extraction and dissolution of OA; thus, this method of administration will affect the absorption of OA in the body, resulting in poor bioavailability that affects its efficacy. Pharmacokinetics data reveals that salidroside is one of the active constituents, and that tyrosol is hard to detect under physiological conditions.

4. Established Mechanisms of Action

4.1 Hepatoprotection via Glutathione Regeneration

The in vivo antioxidant activities of various FLL fractions and oleanolic acid (OLA) were assessed by examining the effect on carbon tetrachloride (CCl₄)-induced hepatotoxicity in mice. Pretreatment of animals with various FLL fractions could protect against CCl₄-induced hepatotoxicity to a varying degree, with OLA-enriched fractions being more potent. OLA pretreatment also produced a dose-dependent protection against CCl₄ hepatotoxicity. The hepatoprotection afforded by OLA pretreatment was associated with an enhancement of hepatic glutathione regeneration capacity (GRC).

Hepatoprotective effects are due to oleanolic acid and are perhaps mediated by an increase in hepatic glutathione regeneration capacity.

An aqueous extract of Ligustrum lucidum enhances cellular antioxidant capacity by activating the AMPK/LKB1 signalling pathway and significantly attenuates CCl₄-induced liver injury.

4.2 Antioxidant and Nrf2 Pathway Activation

Multiple compounds bearing a catechol motif have been identified in L. lucidum, including oleonuezhenide, oleuropein, purpureaside C, calceolarioside B, and esculetin, suggesting that the antioxidant activity of Ligustrum lucidum may be related to these substances. Other structural classes also possess antioxidant activity, including apigenin and triterpenoids such as oleanolic acid and ursolic acid. At the cellular level, oleanolic acid activated the Nrf2 pathway and upregulated antioxidant defences, thereby enhancing cellular resistance to oxidative damage.

4.3 Anti-Osteoporotic Mechanisms

The ethanol extract of L. lucidum and its two primary compounds, ursolic acid and oleanolic acid, significantly inhibit osteoclast differentiation and bone resorption of RAW264.7 murine monocyte/macrophage cells through receptor activator of nuclear factor κB ligand (NF-κB) signaling pathways.

Salidroside and nuzhenide have been identified as potential antiosteoporotic compounds. Ligustrum lucidum has been reported to downregulate iron overload and promote bone formation in ovariectomized (OVX) rat models through the BMP-Smad pathway after continuous administration for almost 2 months.

4.4 Vision-Related Mechanisms

The compound specnuezhenide may confer vision improvement effects via inhibition of the HIF-1alpha/VEGF signaling pathway.

4.5 Antiviral Mechanisms

The secoiridoid glucoside oleuropein has demonstrated antiviral activity against respiratory syncytial virus and parainfluenza type 3 virus, while other secoiridoid compounds showed activity against influenza A virus.

4.6 Anti-Inflammatory Mechanisms (Network Pharmacology)

Through network pharmacology analysis, eight active components including quercetin, luteolin, and kaempferol, and 163 corresponding potential targets—including CCL2, IL6, CXCL8, TNF, and IL1B—were identified. A total of 101 common anti-inflammatory targets were identified by mutual mapping.

4.7 Antidiabetic Mechanisms

Assessment of the antidiabetic and antioxidant effects of OA derived from waxleaf privet leaves in alloxan-induced diabetic rats showed that OA reduced blood glucose levels both in the short term (2 h after administration) and in the long term (40 days), lowered total cholesterol, triglycerides, and LDL cholesterol, and increased HDL cholesterol value.

Ligustrum lucidum is a plant whose fruits are known for their effectiveness in lowering blood glucose levels in normal and diabetic mice, attributed to the active constituent oleanolic acid.

4.8 Antitumor Mechanisms (In Vitro)

In vitro studies suggest antitumor effects occur via immunomodulation and by reverting macrophage suppression brought about by tumors, or are due to increases in phagocytes and lymphokine-activated killer cells. Ligustrum may induce apoptosis in human hepatocellular carcinoma cells via p21 upregulation.

4.9 Enzyme Inhibition

Haemolytic activity and inhibition of oxidative haemolysis as well as the enzyme inhibitory activities (α-amylase enzyme and acetylcholinesterase) were assessed. Results suggested that different biological activities varied according to the region where samples were collected. Results demonstrated that the most efficient extract presented the lowest IC₅₀ values: 10.67 ± 0.46 μg/mL for inhibition of erythrocyte oxidative haemolysis, 58.28 ± 3.77 μg/mL for the α-amylase enzyme, and 67.67 ± 2.10 μg/mL for acetylcholinesterase inhibition.

5. Scientific Evidence by Area of Use

5.1 Liver Protection (Hepatoprotection)

Preclinical evidence: Nuzhenizi (the fruit of Ligustrum lucidum) was reported to possess immunomodulatory, anti-inflammatory, hepatoprotective, anti-tumor, and anti-aging activities. The most mechanistically investigated hepatoprotective property is that of the oleanolic acid fraction, which has been studied in multiple rodent hepatotoxicity models using CCl₄ challenge.

Specnuezhenide (SP), the standard prominent secoiridoid compound of Fructus Ligustri Lucidi, may ameliorate hepatic inflammation in chronic liver diseases. Regulating inflammation through the SIRT6-P2X7R axis has caused the emergence of novel molecular mechanism strategies for reversing hepatic fibrosis. One study focused on the mechanism of SP in modulating the liver inflammatory microenvironment in hepatic fibrosis.

Clinical evidence: Some clinical trials and preclinical studies have examined the pharmacological effects of Ligustrum, focusing on its immune-boosting, anti-inflammatory, and hepatoprotective properties. Research has shown that extracts of Ligustrum lucidum may improve liver function and promote immune cell activity. However, more large-scale human trials are needed to definitively establish clinical efficacy and safety in various therapeutic applications.

Evidence strength: The hepatoprotective evidence is predominantly from animal models and in vitro cell studies. Robust human clinical trial data is lacking.

5.2 Immune Modulation and Cancer Adjunct Therapy

In vitro and animal evidence: In vitro studies suggest that the fruits of Ligustrum lucidum have antitumor, immunomodulatory, antidiabetic, antiosteoporotic, antiviral, antimutagenic, hepatoprotective, and cytotoxic effects.

Ligustrum refers to a plant, specifically Ligustrum lucidum, that is used in China as an adjunctive therapy to enhance the effects of chemotherapy and radiation therapy in cancer treatment by stimulating hematopoiesis and restoring immune function.

Ligustrum combined with Siberian ginseng may have protective effects against chemotherapy-induced myelosuppression.

Human clinical evidence: Data in humans are quite limited. In a small study of non-small cell lung cancer patients undergoing chemotherapy, a formula containing reishi mushroom and Ligustrum was found to help maintain quality of life. Additional studies to confirm efficacy and safety are needed.

Preliminary studies have suggested that ligustrum may be a beneficial adjuvant therapy for chemotherapy patients. However, there is little meaningful scientific evidence that ligustrum provides any benefit for these or any other conditions.

Ligustrum lucidum has not been shown to treat cancer in humans.

Evidence strength: Weak to preliminary for clinical use. Mechanistic and in vitro data exist, but high-quality randomized controlled trials in humans are absent. The quality-of-life finding in the lung cancer trial was in a small population, used a combination formula (not privet alone), and requires independent replication.

5.3 Bone Health and Anti-Osteoporosis Effects

Preclinical evidence: Ligustrum lucidum has traditionally been used for the treatment of bone diseases in TCM for thousands of years. As one of the liver and kidney-tonifying herbs consistent with the TCM theory of "kidney governing bones," L. lucidum is especially applied to prevent and treat postmenopausal osteoporosis. It also exerts anti-osteoporotic effects in diabetes-induced osteoporosis, senile osteoporosis, and oxidative stress-related osteoporosis.

In one animal study, an aqueous extract (3.5 g/kg) was daily and orally administered to ovariectomized rats for 14 weeks, compared with a control group that received saline alone. The level of calcium-sensing receptor (CaSR) expression was decreased, and the extract effectively increased short-chain fatty acid (SCFA) levels and calcium absorption.

FLL provides a new option for the prevention and treatment of osteoporosis. However, further scientific evidence is expected from well-designed clinical trials on its bone-protective effects and safety.

Evidence strength: Promising but confined to animal (including ovariectomized rat) models and cell culture assays. No human clinical trials of sufficient quality are currently documented.

5.4 Vision and Ophthalmic Uses

Ligustrum lucidum is a Chinese medicinal herb used to treat poor vision, dizziness, fever, and insomnia, and to increase immune function in cancer patients. In animal models, Ligustrum compounds showed antiosteoporotic and vision-sparing effects.

In TCM, L. lucidum is used in Chinese medicine to treat dizziness, but clinical evidence is lacking. Support for fever treatment is not backed by scientific evidence. There are no data to support the use for insomnia.

Evidence strength: Traditional use is long-established, but human clinical evidence is currently absent.

5.5 Antidiabetic Effects

Owing to its rich pharmacological effects, few side effects, and low toxicity, FLL is widely used clinically to treat hepatitis, diabetes, hyperlipidemia, atherosclerosis, menopausal syndrome, infertility, and tumors. However, this comes from a general practice description rather than clinical trial data. The mechanism of blood glucose lowering has been demonstrated primarily through oleanolic acid in rodent diabetic models (vide supra, Section 4.7).

Evidence strength: Animal model evidence exists for the antidiabetic activity of oleanolic acid from L. lucidum. Controlled human clinical trial data for L. lucidum specifically as an antidiabetic agent are not documented in the peer-reviewed literature reviewed.

5.6 Antiviral Activity

The secoiridoid glucoside oleuropein has demonstrated antiviral activity against respiratory syncytial virus and parainfluenza type 3 virus, while other secoiridoid compounds showed activity against influenza A virus. These findings are exclusively from in vitro (cell culture) assays.

Evidence strength: In vitro only. No human clinical trials on antiviral use have been identified.

5.7 Anti-inflammatory Activity

Accumulating evidence has indicated that oleanolic acid and ursolic acid from L. lucidum have exerted anti-aging, anti-inflammatory, antidiabetic, antioxidative, antitumor, antimutagenic, and anti-osteoporosis properties in in-vivo and in-vitro experimental studies.

Evidence strength: In vitro and animal model data. No human clinical evidence is documented specifically for the anti-inflammatory action of L. lucidum.

5.8 Er Zhi Wan Formula and Hepatocellular Carcinoma (Network Pharmacology)

Er-Zhi-Wan (EZW), a well-known TCM formula containing Fructus Ligustri Lucidi and Ecliptae Herba, is commonly used in clinical practice to prevent and treat liver diseases. Modern pharmacological studies have shown that both herbs can inhibit HCC proliferation. However, the pharmacological mechanism, potential targets, and clinical value of EZW in inhibiting HCC have not been fully elucidated.

Using multilevel databases, network pharmacology showed that EZW suppresses hepatocellular carcinoma (HCC) through 19 active components acting on 66 potential targets. Enrichment analysis revealed that EZW mainly regulates HCC progression through various metabolic pathways, the cell cycle, and cellular senescence.

Evidence strength: Computational/network pharmacology only; no clinical trial evidence for this formula against HCC is documented from the sources reviewed.

6. Body Systems and Health Areas Associated with Privet

As an excellent medicinal plant with the homology of medicine and food, L. lucidum is rich in nutrients and active ingredients and consequently has a variety of biological properties such as anti-osteoporosis, antioxidant, liver protection, anti-inflammatory, and analgesic activity, as well as effects on the central nervous system and glucose metabolism, especially excellent anti-tumor activity.

Based on the peer-reviewed literature, the following body systems and health domains are most prominently associated with L. lucidum:

• Hepatic/Liver System: Hepatoprotection, anti-fibrotic effects, liver enzyme normalization (animal models); traditional treatment of hepatitis.
• Skeletal System: Anti-osteoporotic activity through osteoclast inhibition and NF-κB pathway modulation (animal and cell models).
• Immune System: Immunomodulation; stimulation of phagocytes and lymphokine-activated killer cells (in vitro); proposed adjunctive role in cancer chemotherapy (preliminary).
• Metabolic/Endocrine System: Blood glucose lowering (animal models); lipid profile improvement (animal models).
• Ophthalmic System: Traditional use for vision support; specnuezhenide shows HIF-1alpha/VEGF pathway inhibition relevant to retinal protection (preclinical only).
• Antiviral/Infectious Disease: In vitro activity against RSV, parainfluenza, and influenza A viruses via secoiridoid glucosides.
• Oncology (Adjunct): Preliminary evidence for quality-of-life support in chemotherapy patients (combination formula).

7. Dosage Forms and Dosages Reported in Sources

The following dosages are reported as used in traditional practice and/or specific studies; they are presented as a factual record of what sources describe and are not recommendations:

• Dried fruit (traditional TCM dose): The Chinese Pharmacopoeia records a dosage of 6–12 g of the dried fruit.
• Dried fruit (broader traditional range): Typical treatment dosage of the dried fruit is 6 to 20 g per day.
• Dried leaves: The typical treatment dosage of the dried leaves is 40 to 75 g per day.
• Animal study (aqueous extract, osteoporosis model): The extract (3.5 g/kg) was daily and orally administered to ovariectomized rats for 14 weeks.
• Polysaccharide content of processed product: The polysaccharide content of the processed product is approximately 8.7041–9.516 mg/g.
• Er Zhi Wan formula composition: Er Zhi Wan contains two herbs, Fructus Ligustri Lucidi and Herba Ecliptae, by weight ratio (1:1).

8. Safety Considerations and Interactions

8.1 General Safety Profile

Although L. lucidum has been used as a critical tonic in different traditional medical systems worldwide for centuries, data on the systematic safety evaluation of this herb is still insufficient, and toxicological experiments have been seldom reported.

Acute and subacute toxicity studies show that FLL is well tolerated and presents no safety concerns at doses examined in preclinical studies. Ligustrum is generally considered safe when used appropriately in recommended doses, but it may cause mild gastrointestinal upset in some individuals.

8.2 Toxicity at High or Unprocessed Doses

While OLA-enriched fractions protected against CCl₄-induced hepatotoxicity, a mortality rate of 60% was observed in the FLL chloroform-fraction pretreated and CCl₄-intoxicated mice, illustrating that the route of preparation and fraction composition can dramatically alter the safety profile.

8.3 Veterinary and Livestock Concerns

Veterinary reports indicate the potential for digestive disturbance, cardiac effects, and possible neurologic involvement in livestock. Generally some degree of digestive disturbance is seen, ranging from cessation of rumination to severe diarrhea.

8.4 Hypersensitivity

The use of Ligustrum lucidum is contraindicated in individuals with hypersensitivity to the plant.

8.5 Drug Interactions (Potential)

Caution is advised when taking Ligustrum alongside other medications or in high doses. Given that oleanolic acid modulates hepatic enzymes and the Nrf2/glutathione pathway, there is a theoretical basis for interactions with hepatically metabolized drugs, though this has not been specifically quantified in human pharmacokinetic drug interaction studies based on the sources reviewed.

8.6 Note on Raw Fruit vs. Prepared Extract

A distinction in the literature must be emphasized: in TCM, the fruit is used in a dried, sometimes processed (steamed or wine-treated) form, not as raw unprocessed plant material. The bioactive compound profile, particularly the relative proportion of toxic versus beneficial constituents, may differ substantially between the prepared medicinal form and the raw ornamental plant. Sources specifically addressing the ripe, dried, prepared fruit consistently describe it as having a favorable safety profile at traditional doses, while sources addressing the whole ornamental plant raise broader toxicity concerns.

8.7 Insufficient Human Toxicology Data

Although L. lucidum has been used as a critical tonic in different traditional medical systems worldwide for centuries, up to now data on the systematic safety evaluation of this herb is still insufficient, and toxicological experiments were seldom reported. This gap represents a significant limitation in the evidence base.

9. Summary of Evidence Quality

The overall body of scientific evidence for Ligustrum lucidum as a dietary supplement or medicinal herb is characterized by a rich foundation of phytochemical characterization and in vitro mechanistic data, supported by a substantial number of animal model studies, but limited—and in some areas entirely absent—human clinical trial evidence. Modern pharmacological research has been concentrated on the anti-osteoporotic and hepatoprotective activity, with relatively weaker coverage of antioxidant and immunomodulatory activity in clinical settings. In vitro studies suggest it has antioxidant, antitumor, and immune function effects. A few animal studies suggest properties that may have benefits on bone and vision. Data in humans are quite limited.

Traditional Chinese medicine has long used L. lucidum to improve vision and tonify the liver and kidneys, but more recent studies have started to substantiate these uses using pharmacokinetic and mechanistic analyses, primarily in animal models.

References

• PMC11199554 — A review of botany, phytochemistry, pharmacology, and applications of the herb with the homology of medicine and food: Ligustrum lucidum W.T. Aiton (Frontiers in Pharmacology / PubMed Central, 2024)
• Frontiers in Pharmacology — A review of botany, phytochemistry, pharmacology, and applications: Ligustrum lucidum W.T. Aiton (2024)
• PMC6151717 — Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety (Molecules, 2017)
• Memorial Sloan Kettering Cancer Center — Ligustrum lucidum Herb Information
• EBSCO Research Starters — Ligustrum's Therapeutic Uses
• PubMed 11746839 — Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice (Phytother Res, 2001)
• PMC6479620 — Enzyme Inhibitory Potential of Ligustrum lucidum Aiton Berries (2019)
• MDPI Molecules — Fructus Ligustri Lucidi in Osteoporosis: Pharmacology, Phytochemistry, Pharmacokinetics and Safety (2017)
• PMC12108409 — Oleanolic Acid: A Promising Antioxidant—Sources, Mechanisms of Action, Therapeutic Potential (2025)
• Taylor & Francis — Phytochemical profile and in vitro bioactivities of ethanolic extract from Fructus Ligustri Lucidi (2025)
• ScienceDirect — Ligustri Lucidi Fructus, a traditional Chinese Medicine: Comprehensive review of botany, traditional uses, chemical composition, pharmacology, and toxicity (2022)
• SAGE Journals — Chemical Constituents From the Fruits of Ligustrum lucidum W.T. Aiton and Their Role on the Medicinal Treatment (2020)
• PMC9699749 — Multilevel data integration and molecular docking approach to elucidate the pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma (2022)
• PMC9699142 — Optimization of Formulation Parameters in Preparation of Fructus ligustri lucidi Dropping Pills (2022)
• PMC8473267 — Protective Effects of Water Extract of Fructus Ligustri Lucidi against Oxidative Stress-Related Osteoporosis In Vivo and In Vitro (2021)
• PubMed 26882695 — Ligustrum lucidum and its Constituents: A Mini-Review on the Anti-Osteoporosis Potential (2016)
• PubMed 20575386 — Chemical constituents from fruits of Ligustrum lucidum (2010)
• ITM Online — Erzhi Wan: Two Ultimate Pill
• PMC7710427 — Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives (2020)
• IOS Press — Anti-Inflammatory Mechanism of Ligustrum lucidum Ait Based on Network Pharmacology and Molecular Docking (2023)
• ScienceDirect Topics — Ligustrum lucidum Overview